Luba is a veteran biotech, pharmaceutical, tech, and life science tools investor and company builder. Luba serves as the Managing Partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital, which she has built and launched. She has also co-founded Cathay Health, where she serves as the Managing Partner. Luba is a professor at Harvard University in the School of Engineering and Applied Sciences.
Luba has recently served in leadership roles at Google Life Sciences and as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. Luba has led $5B+ in deals and investments across multiple therapeutic areas and life sciences and tech sectors globally. She has also co-founded biotech and digital health companies in the immunotherapy, AI/ML, women’s health and microbiome space, including In8Bio and Luca Biologics.
She serves on numerous boards, including the Massachusetts Biotechnology Council (MassBio), Kojin, Brooklyn ImmunoTherapeutics, BenchSci, and Entrinsic Health. And has served as a Senior Advisor to the CEO of the Dana-Farber Cancer Institute as well as the Wyss Center for Bio and Neuroengineering. She is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst, and a Founder of the Pharma Digital Health Roundtable. She has served on numerous non-profit boards including the Longwood Symphony Orchestra, advised on global Covid response efforts, including Covid SafePaths, and serves on Investor Committee for the National Cancer Institute.
Luba is also a former litigator and regulatory, policy, and IP expert, having started her career at Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology.